Risk factor burden drives adverse outcomes in gene-negative hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) has traditionally been viewed as a monogenic disease. Increasing evidence, however, suggests that gene-elusive HCM constitutes a distinct subgroup. A clearer understanding of its natural history is essential to support tailored management strategies. To characterise clinic...